Biomarker-driven drug development for allergic diseases and asthma: An FDA public workshop.

Saved in:
Bibliographic Details
Title: Biomarker-driven drug development for allergic diseases and asthma: An FDA public workshop.
Authors: Rabin RL; Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, Md. Electronic address: ronald.rabin@fda.hhs.gov., Altman MC; University of Washington, Seattle, Wash., Arshad SH; Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom., Beger RD; National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, Ark., Frischmeyer-Guerrerio PA; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md., Goleva E; Department of Pediatrics, National Jewish Health, Denver, Colo., Hamilton RG; Johns Hopkins University School of Medicine, Baltimore, Md., Khurana Hershey GK; Division of Asthma Research, Cincinnati Children's Hospital, Cincinnati, Ohio., Shamji MH; Immunomodulation and Tolerance Group, Allergy and Clinical Immunology, Department of National Heart and Lung Institute, Imperial College London, London, United Kingdom., Sampson HA; Department of Pediatrics, Jaffe Food Allergy Institute, Icahn School of Medicine at Mount Sinai, New York, NY., Santos AF; Department of Women and Children's Health (Pediatric Allergy), School of Life Course and Population Sciences & Peter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, and the Children's Allergy Service, Evelina London Children's Hospital, Guy's and St Thomas' Hospital, London, United Kingdom., Shreffler WG; Food Allergy Center, Division of Pediatric Allergy and Immunology, and the Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital, and the Department of Pediatrics, Harvard Medical School, Boston, Mass., Togias A; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md., Vieths S; Molecular Allergology, Paul-Ehrlich-Institut, Langen, Germany., Wambre E; Jaffe Food Allergy Institute, Icahn School of Medicine at Mount Sinai, New York, NY., Wenzel SE; Department of Environmental and Occupational Health, School of Public Health, University of Pittsburgh, Pittsburgh, Pa., Hise K; Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, Md., Lee J; Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, Md., Tripathi A; Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, Md., Slater JE; Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, Md.
Source: The Journal of allergy and clinical immunology [J Allergy Clin Immunol] 2025 Jun; Vol. 155 (6), pp. 1753-1766. Date of Electronic Publication: 2025 Mar 26.
Publication Type: Conference Proceedings
Journal Info: Publisher: Mosby Country of Publication: United States NLM ID: 1275002 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6825 (Electronic) Linking ISSN: 00916749 NLM ISO Abbreviation: J Allergy Clin Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1097-6825
DOI:10.1016/j.jaci.2025.03.014